Companies/MeiraGTx Holdings plc
Company profile

MeiraGTx Holdings plc

NASDAQ: MGTX · Healthcare · Biotechnology
PublicHQ New York City, NY · New YorkCIK 0001735438Reports USD
#372 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
48D
Revenue TTM
$79.8M
Rev growth YoY (TTM)
+131.1%
Net income (FY)
-$114.2M
Employees
409
as of 2026-08-10
Market cap
$1.2B
as of 2026-08-10

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$81.4M$81.4M2025
Net income-$114.2M-$114.2M2025
Operating income-$106.0M-$106.0M2025
Total assets$244.4M$244.4M2025
Liabilities$250.2M$250.2M2025
Equity-$5.8M-$5.8M2025

Revenue trend

FY2019 – FY2025 · USD
FY19
FY20
FY21
FY21
FY24
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
License92%
Related Party Service Revenue8%
By geography

Not disclosed.

The read

What is MeiraGTx Holdings plc’s revenue?

MeiraGTx Holdings plc booked $81.4M in FY2025 revenue, growing 145% year over yearfaster than most Healthcare companies we track, at a -140.3% net margin.

Key facts
CEOAlexandria Forbes
SectorHealthcare
IndustryBiotechnology
HeadquartersNew York City, NY
ExchangeNASDAQ: MGTX
Employees409
IPO date2018-06-08
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.